The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder
- 1 October 1968
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 34 (2) , 291-310
- https://doi.org/10.1111/j.1476-5381.1968.tb07052.x
Abstract
In the intact conscious dog, caerulein causes emesis and evacuation of the bowel. The mean effective dose by the intravenous route is 0.4–0.5 μg/kg, and by the subcutaneous route 3–4 μg/kg. The gall bladder in situ or as an isolated preparation is highly sensitive to caerulein. A few ng/kg injected intravenously are sufficient to stimulate the gall bladder in situ and less than 1 ng/kg per min is effective when infused intravenously. The isolated gall bladder is contracted by caerulein in concentrations as low as 0.03–2 ng/ml. Krebs solution. There is no tachyphylaxis but, generally, a good dose‐response relationship. Hence the gall bladder, especially that of the guinea‐pig, appears to be very suitable for the bioassay of caerulein and related peptides. In situ, the musculature of the gastrointestinal tract is also highly sensitive to caerulein. Doses as low as 1–5 ng/kg, administered intravenously, have a spasmogenic action on jejunal loops of the dog, and slightly larger doses contract the small intestine of the cat. The stomach and the large intestine seem to be somewhat less sensitive to the polypeptide. Caerulein has a considerable spasmogenic action on the rat pylorus but relaxes the sphincter of Oddi of the guinea‐pig. Isolated preparations of the gastrointestinal tract are relatively insensitive to caerulein and tachyphylaxis occurs readily. Blockade with atropine produces different effects in different intestinal segments and in different animal species. The spasmogenic action of caerulein on the gall bladder is atropine‐resistant. The effects of caerulein are similar to those of cholecystokinin‐pancreozymin in the organs tested in situ or as isolated preparations. Caerulein, however, is always more potent than cholecystokinin‐pancreozymin, even on a molar basis. Compared with caerulein, human gastrin I has negligible activity. The possible use of caerulein in cholecystography is discussed.Keywords
This publication has 13 references indexed in Scilit:
- THE ACTION OF CAERULEIN ON THE SYSTEMIC ARTERIAL BLOOD PRESSURE OF SOME EXPERIMENTAL ANIMALSBritish Journal of Pharmacology, 1968
- Secretory response of the human pancreas to continuous intravenous infusion of pancreozymin-cholecystokinin (Cecekin).Gut, 1967
- Effect of Cholecystokinin on Small IntestineActa Physiologica Scandinavica, 1967
- Effects of Gastrin and its Analogues on Isolated Smooth MusclesNature, 1967
- The role of gastrin in gastroileocolic responsesDigestive Diseases and Sciences, 1967
- THE DETECTION AND ESTIMATION OF BRADYKININ IN THE CIRCULATING BLOODBritish Journal of Pharmacology and Chemotherapy, 1967
- Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozyminBiochemical and Biophysical Research Communications, 1967
- EFFECT OF GASTRIN II ON THE MOTILITY OF THE GASTROINTESTINAL TRACTThe Lancet, 1966
- PHARMACOLOGICAL ACTIONS OF ELEDOISIN ON EXTRAVASCULAR SMOOTH MUSCLEBritish Journal of Pharmacology and Chemotherapy, 1962
- On the Biological Assay of Gholecystokinin and Its Dosage in CholecystographyActa Physiologica Scandinavica, 1960